Intelligencia AI ^Companies

Intelligencia.ai is an organization that specializes in using artificial intelligence (AI) to transform drug development in the pharmaceutical industry. Their main goal is to de-risk the drug development process by providing AI-driven insights and solutions. They offer a suite of solutions that assess the likelihood of success for drugs across multiple therapeutic areas, bolster internal risk identification, pinpoint underlying drivers contributing to technical and regulatory risk, explore risks influencing the drug development pipeline, review the competitive landscape for acquisition, licensing, and portfolio strategies, detect predictive signals, optimize clinical trial design, and standardize risk evaluation processes across entire portfolios. Their achievements include providing trusted AI transparency and helping pharmaceutical companies make confident business decisions in clinical development.